PM Modi said more than 20 renowned research institutions like IITs, Council of Scientific and Industrial Research (CSIR), and ...

Considering its robust fundamentals, strategic positioning under the BioE3 policy, and strong growth potential, we believe ...

Prime Minister Narendra Modi unveiled the genome sequencing data of 10,000 Indian nationals, marking a significant milestone ...

We recently compiled a list of the 12 Best Growth Stocks Under $25 to Buy Now. In this article, we are going to take a look ...

We recently compiled a list of the 12 Best Growth Stocks Under $25 to Buy Now. In this article, we are going to take a look ...

The core components of CRISPR-based genome-editing therapies are bacterial proteins called nucleases that can stimulate ...

Political and economic uncertainty hangs over the industry, while major bets on metabolic and immune disease drug research are set to play out.

Analysts think these stocks are high quality options for blue chip investors. The post 3 no-brainer ASX 200 blue chip stocks ...

Many people believe that as they approach and enter retirement, they should be shedding most or all of their stocks. They assume that since the stock market can be volatile, they should stick with ...

The industry continues to face financial and regulatory headwinds, including high interest rates and uncertainty about ...

Learn more about Zhengye Biotechnology Holding Limited's (ZYBT) stock grades for Value and determine whether this Pharmaceuticals stock meets your investment needs.

Vir Biotechnology's recent share price rally is driven by their promising cancer program. Having shot to over a $1.5B market ...